GNR-068

BIOLOGICAL2 trials

Sponsors

AO GENERIUM

Conditions

Healthy VolunteersPlaque Psoriasis

Phase 1

A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers

CompletedNCT06481215

AO GENERIUMHealthy Volunteers

Start: 2022-03-11End: 2022-12-20Updated: 2024-07-01

Phase 3

An Efficacy and Safety Study of GNR-068 (Ustekinumab Biosimilar) and Stelara® in the Treatment of Patients With Moderate to Severe Plaque Psoriasis

Active, not recruitingNCT06488664

AO GENERIUMPlaque Psoriasis

Start: 2023-07-25End: 2025-09-30Updated: 2025-07-30